Scientific intelligence for emerging technology strategy.
Fenway Scientific Group helps pharma, life sciences, and deep-tech organizations evaluate emerging scientific trends, innovation opportunities, and technology landscapes.
A focused engagement model.
Fenway Scientific Group helps pharma, life sciences, and deep-tech organizations evaluate emerging scientific trends, innovation opportunities, and technology landscapes. Every engagement is led by PhD-level specialists, scoped to the question at hand, and delivered in formats designed for executive and investment decision-making.
Core capabilities
Emerging technology scouting and evaluation
Scientific workshops and executive briefings
Innovation landscape analysis and strategic reporting
Scientific trend interpretation
Cross-disciplinary technology insight
What the work looks like.
- Identifying emerging scientific opportunities
- Evaluating disruptive technologies
- Executive-level scientific workshops
- Cross-industry innovation mapping
- Strategic technology monitoring
Who we work with.
[ C01 ]
Pharma organizations
[ C02 ]
Corporate R&D groups
[ C03 ]
Innovation strategy teams
[ C04 ]
Deep-tech companies
[ C05 ]
Scientific leadership teams
How the engagement moves.
A measured arc from question to evidence-led recommendation — calibrated to the decision at hand.
Define strategic innovation focus
We work with leadership to frame the strategic question — which domains, which timeframes, which decisions the work must inform.
Assemble subject matter expertise
We activate specialists across biology, chemistry, neuroscience, and materials to match the breadth of the innovation question.
Analyze technology and research landscape
Structured analysis of the scientific literature, competitive activity, and adjacent fields surfacing genuinely emergent signals.
Deliver structured innovation insight
Executive briefings, written landscape reports, and workshops calibrated to the technical depth of the decision-makers in the room.